Edward Lifesciences was downgraded to market perform at Leerink. $105 price target. Sales ramp may be slower than expected, Leerink said.
Tesoro (TSO) was upgraded to overweight from neutral at JPMorgan. $99 price target. Tesoro was also added to the Analyst Focus List. The valuation is more attractive, as the stock has lagged since the election, JPMorgan said.
This article was written by a staff member of TheStreet.